Dorota Jamrozy
Wellcome Trust Sanger Institute, UK, United Kingdom
- This delegate is presenting an abstract at this event.

Dr. Dorota Jamrozy is a principal bioinformatician and project manager for the Juno study at the Sanger Institute. With a background in bacterial genomics, her expertise lies in applying whole-genome sequencing to investigate pathogen evolution. Dr. Jamrozy holds a BSc in Medical Biology from Brunel University and a PhD in Microbiology from Kingston University, London, complemented by training in microbiology and molecular biology. Since joining the Sanger Institute in 2014, she has been involved in multiple genomic studies on human-associated bacterial pathogens such as Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae. Her current research focuses on the global diversity and evolution of Group B Streptococcus.
Presentations this author is a contributor to:
Fluoroquinolone-resistant group B Streptococcus is associated with a serotype V ST19 sublineage frequently detected among semen samples in Brazil (118375)
2:39 PM
Tatiana Pinto
Concurrent 1a - Microbiology
Analysis of the global Group B Streptococcus pangenome: insights into genetic diversity and evaluation of potential vaccine targets of GBS (118596)
9:57 AM
Nida Javaid
Plenary 1 - A Global View
Distinguishing genetic features of Group B Streptococcus infection in neonates and adults (119051)
11:51 AM
Dorota Jamrozy
Plenary 8 - Surveillance, Transmission, and Public Health Interventions